Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions
Abstract Tetrahydrocannabinol (THC) is the primary psychoactive ingredient in cannabis. While the safety of THC and cannabis has been extrapolated…
medical marijuana
Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews
Abstract Background: Although cannabis and cannabinoids are widely used with therapeutic purposes, their claimed efficacy is highly controversial. For this…
Benefits and harms of medical cannabis: a scoping review of systematic reviews
Abstract Background: There has been increased interest in the role of cannabis for treating medical conditions. The availability of different…
Cannabis-based medicines and the perioperative physician
Abstract The increasing availability of cannabis for both recreational and medicinal purposes means that anaesthetists will encounter an increasing number…
Priming primary care providers to engage in evidence-based discussions about cannabis with patients
Abstract Cannabis use has become increasingly common in the U.S. in recent years, with legalization for medical and recreational purposes…
Medical Cannabis for the Primary Care Physician
Abstract Medical cannabis use is common in the United States and increasingly more socially acceptable. As more patients seek out…
Potency Analysis of Medical Marijuana Products from New York State
Abstract Introduction: In the United States, medical marijuana programs have been established in 29 states and the District of Columbia.…
Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever
Abstract Objective: Unusual setting of medical care Background: Colchicine-resistant familial Mediterranean fever can be treated by anti-IL-1 biologic therapy; however,…
Tracking and Reporting Outcomes in Medical Marijuana: Establishing Condition Specific State Level Registries
Abstract In a previous commentary in INNOVATIONS in pharmacy, the question was raised as to the questions legislators should ask…
Establishing Practice Risk Management and Outcomes Claims for Medical Marijuana Dispensaries: Questions Legislators Should Ask
Abstract In a previous commentary in INNOVATIONS in Pharmacy, the case was made that a major oversight in approving the…